Molecular Docking Studies of Squalen Synthase Inhibitors as Potential Anti Cardiovascular Disease Drugs: Insights into Drug-Protein Interaction Discovery

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmaceutical Sciences

• Publication date

  2013-12-16

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.

  2011cited by this paper
• Design of more potent squalene synthase inhibitors with multiple activities.

  2010influential reference
• PTools: an opensource molecular docking library

  2009cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Computational docking of biomolecular complexes with AutoDock.

  2009cited by this paper
• Using AutoDock for Ligand‐Receptor Docking

  2008cited by this paper
• Cloning, Solubilization, and Characterization of Squalene Synthase from Thermosynechococcus elongatus BP-1

  2008cited by this paper
• Ligand docking and structure-based virtual screening in drug discovery.

  2007cited by this paper
• Kinetic Characterization of Squalene Synthase from Trypanosoma cruzi: Selective Inhibition by Quinuclidine Derivatives

  2007cited by this paper
• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

  2007cited by this paper
• Isolation and structural determination of squalene synthase inhibitor from Prunus mume fruit.

  2007cited by this paper
• HMG-CoA reductase inhibitors

  2007cited by this paper
• Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes.

  2003cited by this paper
• Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels.

  2003cited by this paper
• HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

  2001cited by this paper
• Crystal Structure of Human Squalene Synthase

  2000cited by this paper
• Truncation of human squalene synthase yields active, crystallizable protein.

  1998cited by this paper
• VMD: visual molecular dynamics.

  1996cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems.

  1995cited by this paper

• Lupane derivatives: Design, isolation, synthesis and evaluation of antiplasmodial activity against Plasmodium falciparum 3D7 strain

  2023cites this paper
• Lipoxygenase inhibition and molecular docking studies of secondary metabolites from the leaves of Alstonia scholaris

  2023cites this paper
• The investigation into the effect of the length of RGD peptides and temperature on the interaction with the αIIbβ3 integrin: a molecular dynamic study

  2021cites this paper
• ISOLATION, CHARACTERIZATION, AND DOCKING STUDIES OF ISOLATED COMPOUNDS AS ANTIDIABETIC MOLECULES FROM CRESSA CRETICA

  2020cites this paper